VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESGO 2021 | Improving immunotherapy outcomes in ovarian cancer

Eric Pujade-Lauraine, MD, PhD, Hôpital Hôtel-Dieu, Paris, France, outlines approaches to improve outcomes in patients with ovarian cancer treated with immune checkpoint inhibitors, including combinations with chemotherapy as well as bevacizumab. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter